Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|15|8|739-749

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.8, 2015-01, pp. : 739-749

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CDK9 a Potential Target for Drug Development

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

ATP-noncompetitive CDK inhibitors for cancer therapy: an overview

By Abate Agnese Anna  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 895-906

Informa Healthcare

Access to resources Recommend Favorite

CDK inhibitors in clinical development for the treatment of cancer

By Fischer Peter M   Gianella-Borradori Athos  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 955-970

Informa Healthcare

Access to resources Recommend Favorite

Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells

By  

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1609-1619

Bentham Science Publishers

Access to resources Recommend Favorite

Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)

By  

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 741-752

Bentham Science Publishers

Access to resources Recommend Favorite